Silver Book Fact

Increased use of a blood-thinning drug prevents 40,000 strokes every year in the U.S.

Secondary and Tertiary Prevention of Stroke Patient Outcomes Research Team Final Report — Phase 1. AHRQ Web site. http://www.ahrq.gov/clinic/strokcln.htm. Published June 2000

Reference

Title
Secondary and Tertiary Prevention of Stroke Patient Outcomes Research Team Final Report — Phase 1
Publication
AHRQ
Publication Date
Published June 2000
Authors
Matchar D, Samsa G
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Cost of warfarin therapy for AFib patients
    In patients with nonvalvular atrial fibrillation (AF) and one additional stroke risk factor, warfarin therapy cost $8,000 per quality-adjusted life-year (QALY) saved.  
  • From 1999-2000, average blood pressures for Americans age 40 and older would have been 10-13% higher without antihypertensive drug therapy.  
  • From 1970-2000, gains in longevity were greatest for people between the ages of 40 and 60, and greater for men than women, in large part because of advances in the…  
  • The rise in beta-blocker treatment rates (34% since 1996) is proof that sustained attention and effective initiatives saves lives and improves quality of life.  
  • 5 years of treatment with beta-blockers for heart failure increases patient survival by about 3 1/2 months and patients had fewer overnight hospital stays.